Initiation of Antiresorptive Drug Treatment during Endocrine Therapy for Breast Cancer—A Retrospective Cohort Study of 161,492 Patients in Germany

Endocrine therapy (ET), which significantly reduces breast cancer (BC) recurrence and mortality rates, is the primary systemic therapy for hormone receptor positive BC. However, in addition to frequently reported TAM- and AI-related side effects, such as hot flashes, arthralgias, and myalgias, treat...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Gremke, Niklas, Griewing, Sebastian, Kadys, Arturas, Kostev, Karel, Wagner, Uwe, Kalder, Matthias
Materyal Türü:	Makale
Dil:	İngilizce
Baskı/Yayın Bilgisi:	Philipps-Universität Marburg 2023
Konular:	endocrine therapy denosumab Medizin bisphosphonates Germany breast cancer tamoxifen antiresorptive therapy aromatase inhibitors Medical sciences Medicine
Online Erişim:	PDF Tam Metin
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!